PathGroup attracts private equity investment to fuel M&A, Texas expansion

PathGroup, one of the largest independent labs in the U.S., has formed an investment partnership with private equity firm GTCR.

GTCR made a majority investment in the company, the companies said May 13. As part of the deal, former Labcorp CEO and chairman Dave King is joining PathGroup's board as chairman. 

The investment is intended to support PathGroup's expansion into Texas and other areas, as well as mergers and acquisitions.

The terms of the transaction were not disclosed.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars